Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessAuthor Correction: Liquid biopsy epigenomic profiling for cancer subty**
-
Article
Open AccessLiquid biopsy epigenomic profiling for cancer subty**
Although circulating tumor DNA (ctDNA) assays are increasingly used to inform clinical decisions in cancer care, they have limited ability to identify the transcriptional programs that govern cancer phenotypes...